Search information on this website by using terms such as ‘vising times at Rotherham Hospital’ or ‘health visiting services in Rotherham.’

Using more general terms may bring up results from outside of Rotherham health services.

Due to COVID-19 coronavirus, we are having to make temporary changes to our services. Click here to find out more Temporary Changes


‘Big thank you’ to the Trust’s research team

18 Sep 2020 11:56:35
Research team

The Trust has received huge thanks from the team behind the national GenOMICC study into Covid-19 and the effects on patients.

The GenOMICC team sent an email to the Trust’s research team thanking them for their part in recruiting patients to the study. It said: “Another busy week has reached its end and the team here at GenOMICC would like to take this time to say a big thank you for all the enthusiasm your team at Rotherham Hospital has put into recruiting patients to the study. We are pleased to say that you are in the top three of all the sites involved in the project in the past 14 days (of which there are over 200!). We really appreciate the effort! Thank you once again.” 

Rachel Walker, Lead Research Nurse, said the GenOMICC study was ground-breaking research that has the potential to dramatically improve our understanding of Covid-19. 

She said: “It could help us to identify whether underlying genomic differences play a part in how people react to the virus and why some people have few or no symptoms, while others can get very ill.  

“We approached patients who had been on critical care with Covid-19 at TRFT and had an amazing response, with 10 patients contacting us in just a few days to participate. 

“The data that is collected during the study will also inform global strategic planning for possible later waves of the pandemic, and for new pandemics in the future.” 

As we’ve previously reported, the Trust is one of the sites hosting the GenOMICC’s study sponsored by the University of Edinburgh to sequence human genomes in the fight against Covid-19. The study aims to sequence the genomes of 20,000 people who are severely ill with Covid-19, and a further 15,000 individuals with mild symptoms. The study will help us better understand the virus’ varied effects on people and support the search for treatments.